Non-Hodgkin lymphoma (NHL) originates in the cells of the lymphatic and immune systems, such as the blood cells known as lymphocytes and the lymph node tissues. NHL accounts for approximately 4.3% of all cancer diagnoses and is the seventh most common cancer in men and the sixth most common cancer in women. According to the American Cancer Society, approximately 81,560 individuals (45,630 males and 35,930 females, including both adults and children) will be diagnosed with NHL in the United States in 2021, and approximately 20,720 individuals (12,170 males and 8550 females) will die from the disease. The survival rate for NHL has steadily improved over the past 2 decades, due to improvements in medical care, the development and approval of more effective therapies, and the advent of personalized medicine. How much do you know about NHL?
According to the American Cancer Society, approximately 106,110 individuals (62,260 men and 43,850 women) will be diagnosed with melanoma in the United States in 2021, and approximately 7180 individuals (4600 men and 2580 women) will die from the disease. The risk for developing melanoma increases as individuals get older, with a median age at diagnosis of 65 years. However, it is also one of the most common cancers diagnosed in young adults, particularly in women aged <29 years. Although melanoma accounts for only 1% of all skin cancer diagnoses, it is responsible for a large majority of skin cancer deaths. How much do you know about melanoma?
Results 1 - 10 of 50